Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

NCT03747120 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Pembrolizumab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]